The state-of-the-art on cancer from different perspectives
Topics go from fundamental research to the translational application into the clinic
Targeted therapies in cancer models such as breast cancer or lung cancer are minutely detailed
Examples of multidisciplinary fights against cancer
First-line European projects described
This volume contains the lectures held at the International Symposium on Cancer "New Trends in Cancer for the 21st Century". Fundamental researchers, politicians and representatives from patient coalitions share their knowledge and interests as well as their concerns and experiences. Not only do these papers provide state-of-the-art information on cancer, they are also an opportunity to look at the problem from different points of view.
|
It is difficult to imagine anyone who has not heard of cancer. This disease can affect families, friends or any one of us at any time in our lives. Every year nearly 3 million Europeans are diagnosed with cancer, leading to around 800,000 deaths per year. These deaths occur not only in aging populations, but also in children and adults who are in the most active period of their lives. This represents a tremendous problem that cannot be ignored by politicians or citizens. Fortunately, there is a constantly growing awareness that although cancer is a problem to be dealt with by clinicians, it should also be the concern of everyone. This volume contains the lectures held at the International Symposium on Cancer "New Trends in Cancer for the 21st Century". Fundamental researchers, politicians and representatives from patient coalitions share here their knowledge and interests as well as their concerns and experiences. Not only do these papers provide state-of-the-art information on cancer, they are also an opportunity to look at the problem from different points of view. It can be encouraging to realise that we are not alone in this fight.
1. Prognostic and Therapeutic Targets in the Ewing´s Family of Tumors (ProTheTs), P. Picci, K. Scotlandi, M. Serra, and A. Rizzi.- 2. Targeted Therapies in Ewing´s Sarcoma K. Scotlandi.- 3. The CCN3 Protein and Cancer, B. Perbal.- 4. Ews-Fli1 in Ewing´s Sarcoma – Real Targets and Collateral Damage, J. Ban, C. Siligan, M. Kreppel, D. Aryee and H. Kovar.- 5. Molecular Karyotyping in Sarcoma Diagnostics and Research, H. Vauhkonen, S. Savola, S. Kaur, M. L. Larramendy and S. Knuutila.- 6. Tubafrost: European Virtual Tumor Tissue Banking, P. H. J. Riegman, M. H. A. Oomen, W. N. M. Dinjens, J. W. Oosterhuis, K. H. Lam, A. Spatz, C. Ratcliffe, K. Knox, R. Mager, D. Kerr, F. Pezzella, B. van Damme, M. van de Vijver, H. van Boven, M. M. Morente, S. Alonso, D. Kerjaschki, J. Pammer, J. A. Lopez-Guerrero, A. Llombart Bosch, A. Carbone, A. Gloghini, I. Teodorovic, M. Isabelle, A. Passioukov, S. Lejeune, P. Therasse and E-B. van Veen.- 7. Virtual Microscopy in Virtual Tumor Banking, M. Isabelle, I. Teodorovic, J. W. Oosterhuis, P. H. J. Riegman and the TuBaFrost Consortium.- 8. Harmonizing Cancer Control in Europe, U. Ringborg.- 9. The Diagnosis of Cancer: 'From H&E to Molecular Diagnosis and Back', J. Costa.- 10. From Morphological to Molecular Diagnosis of Soft Tissue Tumors, M. Miettinen.- 11. Prediction of Response to Neoadjuvant Chemotherapy in Carcinomas of the Upper Gastrointestinal Tract H. Höfler, R. Langer, K. Ott and G. Keller.- 12. Integrating the Diagnosis of Childhood Malignancies, D. López-Terrada.- 13. Preclinical Models for Cell Cycle-Targeted Therapies, M. Malumbres.- 14. WWOX, a Chromosomal Fragile Site Gene and its Role in Cancer, Ramos D. and Aldaz C. M.- 15. From Genome to Proteome in Tumor Profiling, J. K. Habermann, U. J. Roblick, M. Upender, T. Ried and G. Auer.- 16. Effect of Hypoxia on the Tumor Phenotype: the Neuroblastoma and Breast Cancer Models, L. Holmquist, T. Löfstedt and S. Påhlman.- 17. Methylation Patterns andChemosensitivity in NSCLC, J. L. Ramirez, M. F. Salazar, J. Gupta, J. M. Sánchez, M. Tarón, M. Sánchez-Ronco, Vicente Alberola and R. de las Peñas.- 18. Pharmacogenomics and Colorectal Cancer, H. J. Lenz.- 19. Development of Pharmacogenomic Predictors for Preoperative Chemotherapy of Breast Cancer, L. Pusztai.- 20. Vascular Endothelial Growth Factor Inhibitors in Colon Cancer, E. Díaz-Rubio.- 21. Molecular Imaging of Cancer Using PET and SPECT, A. Kjær, B. Celda, D. Monleón, M. C. Martínez-Bisbal, V. Esteve, B. Martínez-Granados, E. Piñero, R. Ferrer, J. Piquer, L. Martí-Bonmatí and J. Cervera.- 23. From Linac to Tomotherapy: New Possibilities for Cure? G. Storme, D. Verellen, G. Soete, N. Linthout, J. Van de Steene, M. Voordeckers, V. Vinh-Hung, K. Tournel, and D. Van den Berge.- 24. Targeting mTOR for Cancer Treatment, B. Rubio-Viqueira and M. Hidalgo.- 25. Dual/Pan-Her Tyrosine Kinase Inhibitors (TKI): Focus in Breast Cancer, J. Albanell.- 26. Anti-Tumor Associated Antigens IGGS. Dual Positive and Negative Potential Effects For Cancer Therapy, E. Barberá-Guillem and J. W. Sampsel.- 27. Synergistic Molecular Mechanisms in Hormone Sensitive Breast Cancer, A. Llombart Cussac.- Contributors.- Index
Prognostic and Therapeutic Targets in the Ewing's Family of Tumors (PROTHETS).- Targeted Therapies in Ewing's Sarcoma.- The CCN3 Protein and Cancer.- Ews-Fli1 in Ewing's Sarcoma: Real Targets and Collateral Damage.- Molecular Karyotyping in Sarcoma Diagnostics and Research.- TuBaFrost: European Virtual Tumor Tissue Banking.- Virtual Microscopy in Virtual Tumor Banking.- Harmonizing Cancer Control in Europe.- The Diagnosis of Cancer: "From H&E to Molecular Diagnosis and Back".- From Morphological to Molecular Diagnosis of Soft Tissue Tumors.- Prediction of Response to Neoadjuvant Chemotherapy in Carcinomas of the Upper Gastrointestinal Tract.- Integrating the Diagnosis of Childhood Malignancies.- Preclinical Models for Cell Cycle-Targeted Therapies.- WWOX, a Chromosomal Fragile Site Gene and its Role in Cancer.- From Genome to Proteome in Tumor Profiling: Molecular Events in Colorectal Cancer Genesis.- Effect of Hypoxia on the Tumor Phenotype: The Neuroblastoma and Breast Cancer Models.- Methylation Patterns and Chemosensitivity in NSCLC.- Pharmacogenomics and Colorectal Cancer.- Development of Pharmacogenomic Predictors for Preoperative Chemotherapy of Breast Cancer.- Vascular Endothelial Growth Factor Inhibitors in Colon Cancer.- Molecular Imaging of Cancer Using PET and SPECT.- MRS as Endogenous Molecular Imaging for Brain and Prostate Tumors: FP6 Project "eTUMOR".- From Linac to Tomotherapy: New Possibilities for Cure?.- Targeting mTOR for Cancer Treatment.- Dual/Pan-Her Tyrosine Kinase Inhibitors: Focus in Breast Cancer.- AntiTumor-Associated Antigens IGGS: Dual Positive and Negative Potential Effects for Cancer Therapy.- Synergistic Molecular Mechanisms in Hormone-Sensitive Breast Cancer.
Inhaltsverzeichnis
Prognostic and Therapeutic Targets in the Ewing's Family of Tumors (PROTHETS).- Targeted Therapies in Ewing's Sarcoma.- The CCN3 Protein and Cancer.- Ews-Fli1 in Ewing's Sarcoma: Real Targets and Collateral Damage.- Molecular Karyotyping in Sarcoma Diagnostics and Research.- TuBaFrost: European Virtual Tumor Tissue Banking.- Virtual Microscopy in Virtual Tumor Banking.- Harmonizing Cancer Control in Europe.- The Diagnosis of Cancer: "From H&E to Molecular Diagnosis and Back".- From Morphological to Molecular Diagnosis of Soft Tissue Tumors.- Prediction of Response to Neoadjuvant Chemotherapy in Carcinomas of the Upper Gastrointestinal Tract.- Integrating the Diagnosis of Childhood Malignancies.- Preclinical Models for Cell Cycle-Targeted Therapies.- WWOX, a Chromosomal Fragile Site Gene and its Role in Cancer.- From Genome to Proteome in Tumor Profiling: Molecular Events in Colorectal Cancer Genesis.- Effect of Hypoxia on the Tumor Phenotype: The Neuroblastoma and Breast Cancer Models.- Methylation Patterns and Chemosensitivity in NSCLC.- Pharmacogenomics and Colorectal Cancer.- Development of Pharmacogenomic Predictors for Preoperative Chemotherapy of Breast Cancer.- Vascular Endothelial Growth Factor Inhibitors in Colon Cancer.- Molecular Imaging of Cancer Using PET and SPECT.- MRS as Endogenous Molecular Imaging for Brain and Prostate Tumors: FP6 Project "eTUMOR".- From Linac to Tomotherapy: New Possibilities for Cure?.- Targeting mTOR for Cancer Treatment.- Dual/Pan-Her Tyrosine Kinase Inhibitors: Focus in Breast Cancer.- AntiTumor-Associated Antigens IGGS: Dual Positive and Negative Potential Effects for Cancer Therapy.- Synergistic Molecular Mechanisms in Hormone-Sensitive Breast Cancer.
Klappentext
This volume contains the lectures held at the International Symposium on Cancer "New Trends in Cancer for the 21st Century". Fundamental researchers, politicians and representatives from patient coalitions share their knowledge and interests as well as their concerns and experiences. Not only do these papers provide state-of-the-art information on cancer, they are also an opportunity to look at the problem from different points of view.
The state-of-the-art on cancer from different perspectives
Topics go from fundamental research to the translational application into the clinic
Targeted therapies in cancer models such as breast cancer or lung cancer are minutely detailed
Examples of multidisciplinary fights against cancer
First-line European projects described
